Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-12-037375
Filing Date
2012-05-15
Accepted
2012-05-15 14:19:32
Documents
4
Effectiveness Date
2012-05-15

Document Format Files

Seq Description Document Type Size
1 8-K a12-12034_18k.htm DEFA14A 25164
2 EX-99.1 a12-12034_1ex99d1.htm EX-99.1 10882
3 GRAPHIC g120341mmi001.jpg GRAPHIC 2919
4 GRAPHIC g120341mmi002.jpg GRAPHIC 1761
  Complete submission text file 0001104659-12-037375.txt   43924
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50626 | Film No.: 12843360
SIC: 2834 Pharmaceutical Preparations